Home / Therapies / Metformin Therapy Center (page 7)

Metformin Therapy Center

Sulfonylureas, Insulin, and Metformin Cancer Risks for Patients with Type 2 Diabetes

Can metformin reduce the risk of cancer for those with type 2 diabetes?… In previous studies, metformin has been shown to decrease the risk of cancer in type 2 diabetes. A recent meta-analysis showed a 34% reduction in the incidence of any cancer and a 33% reduction in cancer mortality; …

Read More »

Metformin for Obese Children

Metformin was linked to reduced food intake, decreased hunger ratings, and increased fullness ratings… For obese hyperinsulinemic children, metformin seems to decrease perceived hunger and increase perceived fullness, according to a published study. Mopelola A. Adeyemo, M.P.H., from the National Institutes of Health in Bethesda, Md., and colleagues examined the …

Read More »

FDA Approves Xigduo XR, a New Dapagliflozin-Metformin Combination

The once-daily oral tablet is the first in the U.S. to combine the SGLT-2 inhibitor dapagliflozin with the biguanide extended-release (XR) metformin hydrochloride.. The US Food and Drug Administration (FDA) has approved a once-daily combination of dapagliflozin and metformin hydrochloride extended-release (Xigduo XR, AstraZeneca) for the treatment of adults with …

Read More »

Metformin Is Best Initial Oral Drug for Lowering Glucose Levels in Diabetes Patients

Metformin, sulfonylureas, thiazolidinedione, and DPP-4 inhibitors were compared to evaluate the effects on the time to subsequent treatment… There are many classes of oral drugs used for diabetes therapy, but there is a lack of evidence as to which drug is best for use as initial therapy. Most patients diagnosed …

Read More »